Inmune Bio, Inc.

Nasdaq:INMB

Biological Products, (No Diagnostic Substances)·BOCA RATON, FL

CEO

Moss David J

CFO

Ellspermann Cory Randall

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	10/30/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	10/31/24	→
10-Q	Q2 2024	6/30/24	8/1/24	→
↓

Earnings Releases (8-K)

9 shown

Filed	Period
10/30/25	Q3 FY2025	→
8/7/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
11/1/24	Q3 FY2024	→
8/2/24	Q3 FY2024	→
↓

News (8-K)

71 shown

Filed	Type	Description
2/27/26	Reg FD	Regulation FD Disclosure	→
2/23/26	Other	Other Events	→
2/19/26	Other	Other Events	→
2/13/26	Reg FD	Regulation FD Disclosure	→
1/27/26	Reg FD	Regulation FD Disclosure	→
12/23/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/19/25	424B5	PROSPECTUS SUPPLEMENT	→
6/30/25	424B5	PROSPECTUS SUPPLEMENT	→
6/16/25	S-8	REGISTRATION STATEMENT	→
6/16/25	S-8	REGISTRATION STATEMENT	→
3/7/25	424B5	PROSPECTUS SUPPLEMENT	→
9/16/24	424B5	PROSPECTUS SUPPLEMENT	→
↓

Filing History(578 filings)

TypeDateAccessionPeriodSize

8-K

Feb 27, 2026

0001213900-26-021120CURRENT REPORT

Feb 27, 2026

17.5 MB

8-K

Feb 23, 2026

0001213900-26-019321CURRENT REPORT

Feb 23, 2026

221.1 KB

8-K

Feb 19, 2026

0001213900-26-018396CURRENT REPORT

Feb 19, 2026

216.6 KB

8-K

Feb 13, 2026

0001213900-26-016385CURRENT REPORT

Feb 10, 2026

284.5 KB

8-K

Jan 27, 2026

0001213900-26-008204CURRENT REPORT

Jan 27, 2026

217.0 KB

8-K

Dec 23, 2025

0001213900-25-125282CURRENT REPORT

Dec 22, 2025

199.7 KB

8-K

Dec 19, 2025

0001213900-25-123880CURRENT REPORT

Dec 19, 2025

509.0 KB

424B5

Dec 19, 2025

0001213900-25-123817PROSPECTUS SUPPLEMENT

—

259.3 KB

8-K

Dec 10, 2025

0001213900-25-120067CURRENT REPORT

Dec 5, 2025

184.7 KB

8-A12B/A

Dec 8, 2025

0001213900-25-119251AMENDMENT NO. 5 TO FORM 8-A12B

—

20.2 KB

8-K

Dec 8, 2025

0001213900-25-119217CURRENT REPORT

Dec 5, 2025

206.1 KB

8-K

Dec 5, 2025

0001213900-25-118699CURRENT REPORT

Dec 1, 2025

235.4 KB

8-K

Dec 3, 2025

0001213900-25-117828CURRENT REPORT

Dec 2, 2025

211.8 KB

Dec 2, 2025

0001213900-25-117311

Dec 1, 2025

5.5 KB

Dec 2, 2025

0001213900-25-117309

Dec 1, 2025

5.5 KB

Dec 2, 2025

0001213900-25-117306

Dec 1, 2025

5.5 KB

Dec 2, 2025

0001213900-25-117305

Dec 1, 2025

5.4 KB

Dec 2, 2025

0001213900-25-117303

Dec 1, 2025

5.4 KB

Dec 2, 2025

0001213900-25-117302

Dec 1, 2025

5.4 KB

Dec 2, 2025

0001213900-25-117300

Dec 1, 2025

5.4 KB

8-K

Nov 28, 2025

0001213900-25-115921CURRENT REPORT

Nov 26, 2025

480.3 KB

Nov 18, 2025

0001213900-25-112241

Nov 18, 2025

38.2 KB

Nov 18, 2025

0001213900-25-112239

Nov 18, 2025

38.3 KB

Nov 18, 2025

0001213900-25-112236

Nov 18, 2025

25.6 KB

Nov 18, 2025

0001213900-25-112232

Nov 18, 2025

38.2 KB

25 filings shown

Filed	Form	Description
10/14/25	DEF 14A	DEF 14A	→
10/3/25	PRE 14A	PRE 14A	→
5/9/25	DEFR14A	REVISED DEFINITIVE PROXY STATEMENT	→
4/25/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
4/21/25	DEF 14A	DEF 14A	→
5/29/24	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
12/8/25	8-A12B/A	AMENDMENT NO. 5 TO FORM 8-A12B	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/2/25	SCHEDULE 13G	SCHEDULE 13G	→
4/10/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓

Inmune Bio, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(578 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/2/25	4	4	→
12/2/25	4	4	→
12/2/25	4	4	→
12/2/25	4	4	→
12/2/25	4	4	→
12/2/25	4	4	→
↓